Long-term Clinical Outcomes After Retinal Artery Occlusion
Recruiting now
Conditions studied: Retinal Artery Occlusion
In brief
Retinal artery occlusion (RAO) is a rare but vision-threatening vascular disorder that is commonly caused by embolic events originating from the heart or carotid arteries. Patients with RAO are known to have an increased risk of subsequent cardiovascular and cerebrovascular events, including ischemic stroke and myocardial infarction. However, long-term outcomes and optimal medical treatment strategies for these patients remain insufficiently characterized. The purpose of this nationwide population-based study is to investigate the incidence of long-term cardiovascular and cerebrovascular outcomes in patients diagnosed with retinal artery occlusion using the Korean National Health Insurance Service (NHIS) database. In addition, the study aims to evaluate the impact of various medical therapies, including antiplatelet agents, anticoagulants, and statins, on long-term clinical outcomes.
Key facts
- Study ID
- NCT07482228
- Run by
- Chonnam National University Hospital
- People needed
- 15000
- Starts
- 2026-03-01
- Expected to finish
- 2027-08-31
- Last updated by the study team
- 2026-03-19
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients newly diagnosed with retinal artery occlusion
You may not qualify if…
- Patients with a prior diagnosis of retinal artery occlusion before the study period.
- Patients diagnosed with giant cell arteritis.
Where it is running
- Chonnam National University Hospital — Gwangju, Gwangju, South Korea (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.